Scientists of BelSU have developed innovative medicine for treatment of osteoporosis

The research of a pathogenetic role of endothelium dysfunction of vessels in development the osteoporethic changes of bones and on development of ways of their effective treatment are conducted was held at BelSU Pharmocological Research Institute of live systems under the leadership of the head of the laboratory, the candidate of medical sciences, associate professor Oleg Gudyrev. Ten years of experiments allowed scientists of BelSU to offer innovative medicine for treatment of osteoporosis and its complications.

– Our scientific researches were directed to studying of osteoporosis and its complications’ development at various pathological states, including diabetes. We hope that the medicine will allow to increase efficiency of prevention and treatment of osteoporosis and will also reduce number of side effects, – Oleg Gudyrev said.